Stocks and Investing Stocks and Investing
Tue, April 30, 2024

Sumant Kulkarni Maintained (ANVS) at Strong Buy with Decreased Target to $26 on, Apr 30th, 2024


Published on 2024-10-28 10:46:23 - WOPRAI, Sumant Kulkarni
  Print publication without navigation


Sumant Kulkarni of Canaccord Genuity, Maintained "Annovis Bio, Inc." (ANVS) at Strong Buy with Decreased Target from $36 to $26 on, Apr 30th, 2024.

Sumant has made no other calls on ANVS in the last 4 months.



There is 1 other peer that has a rating on ANVS. Out of the 1 peers that are also analyzing ANVS, all agrees with Sumant's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • Tyler Bussian of "Brookline Capital" Downgraded from Strong Buy to Hold and Held Target at $9 on, Wednesday, February 28th, 2024
Contributing Sources